Item |
Information |
Drug Groups
|
experimental |
Description
|
1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity. |
Affected Organisms |
• |
Humans and other mammals |
|
References |
• |
Mori Y, Iimura K, Hirano K: N-benzylimidazole, a potent inducer of rat liver enzymes involved in mutagenic activation of various carcinogens. Mutat Res. 1993 Jun;302(2):129-33.
[Pubmed]
|
• |
Lucas J, Chan PS, Mateja N, Cervoni P, Ronsberg MA, Lipchuck LM: 1-Benzylimidazole, a thromboxane synthetase inhibitor acutely lowers blood pressure mainly by alpha-adrenoceptor blockade in spontaneously hypertensive rats (SHR). Prostaglandins Leukot Med. 1983 Dec;12(4):409-21.
[Pubmed]
|
• |
Tuttle RS, Garcia-Minor C, Simon M: Cardiovascular effects of 1-benzylimidazole. J Pharmacol Exp Ther. 1975 Sep;194(3):624-32.
[Pubmed]
|
|
|